Health
International trial of blood thinners for COVID-19 treatment begins – News-Medical.Net
These trials, known as ACTIV-4 Antithrombotics, are part of the three planned adaptive trials in this area of clinical research, included in the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative. They are expected to yield new da…
A recent news release by the National Institutes of Health (NIH) announces the start of two Phase 3 clinical trials to explore blood thinners as treatments for COVID-19.
These trials, known as ACTIV-4 Antithrombotics, are part of the three planned adaptive trials in this area of clinical research, included in the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative. They are expected to yield new data on the safety and efficacy of these drugs in the treatment of activ…
-
Noosa News20 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News22 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
Noosa News18 hours agoFranz Ferdinand: Australian Tour 2025
-
General19 hours agoPostecoglou’s message touches Blues AFL coach Voss after Spurs’ Europa League win